Beta Bionics, Inc.BBNX
Price (close)
$21.51
Market cap
$967.7M
P/E
—
Revenue (TTM)
$119.0M
Net income
-$73.0M
Dividend yield
—
1-year total return
-2.8%
Net margin
-61.3%
Revenue growth
52.5%
Debt / equity
—
What Beta Bionics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | — | $12.0M | $65.1M | $100.3M |
| Net income | — | -$44.1M | -$54.8M | -$73.2M |
| Free cash flow | — | -$32.8M | -$51.7M | -$56.2M |
More on BBNX.
- Beta Bionics, Inc. summary
- Beta Bionics, Inc. financial statements
- Beta Bionics, Inc. key metrics
- Beta Bionics, Inc. health scores and style box
- Beta Bionics, Inc. earnings
- Beta Bionics, Inc. dividends
- Beta Bionics, Inc. valuation
- Beta Bionics, Inc. ownership and insiders
- Beta Bionics, Inc. peers
Figures from Beta Bionics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.